#cobenfy — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #cobenfy, aggregated by home.social.
-
https://www.europesays.com/uk/555960/ New Drug Exposes Hidden Subtypes of Psychosis #BrainResearch #Cobenfy #DisruptedInSchizophrenia1 #Health #Medicine #MentalHealth #neurobiology #Neuroscience #Psychology #psychopharmacology #Science #TuftsUniversity #UK #UnitedKingdom
-
New Drug Exposes Hidden Subtypes of Psychosis
Summary: A new study examining real-world hospital data reveals early indicators of who is most likely to benefit…
#NewsBeep #News #Health #brainresearch #Cobenfy #disruptedinschizophrenia-1 #GB #medicine #Mentalhealth #neurobiology #Neuroscience #Psychology #psychopharmacology #Science #TuftsUniversity #UK #UnitedKingdom
https://www.newsbeep.com/uk/250097/ -
Bristol Myers Squibb has scored a significant victory with the FDA's approval of Cobenfy, a groundbreaking schizophrenia treatment! 🎉 This marks the first new type of schizophrenia drug in over 30 years, offering hope to millions. With its unique mechanism, Cobenfy aims to reduce symptoms without the common side effects of older medications. 💊✨ #MentalHealth #Schizophrenia #Cobenfy #FDAApproved #PharmaInnovation
-
Cobenfy (KarXT): A More Atypical Antipsychotic for Treatment of Schizophrenia
Cobenfy (also known as KarXT), a combination of the drugs xanomeline and trospium chloride, has been studied to be effective for the treatment of...........
#Antipsychotic #Cobenfy #FDA #KarXT #Schizophrenia
Neelesh Prasad -
Cobenfy (KarXT): A More Atypical Antipsychotic for Treatment of Schizophrenia
Cobenfy (also known as KarXT), a combination of the drugs xanomeline and trospium chloride, has been studied to be effective for the treatment of...........
#Antipsychotic #Cobenfy #FDA #KarXT #Schizophrenia
Neelesh Prasad -
Cobenfy (KarXT): A More Atypical Antipsychotic for Treatment of Schizophrenia
Cobenfy (also known as KarXT), a combination of the drugs xanomeline and trospium chloride, has been studied to be effective for the treatment of...........
#Antipsychotic #Cobenfy #FDA #KarXT #Schizophrenia
Neelesh Prasad -
Cobenfy (KarXT): A More Atypical Antipsychotic for Treatment of Schizophrenia
Cobenfy (also known as KarXT), a combination of the drugs xanomeline and trospium chloride, has been studied to be effective for the treatment of...........
#Antipsychotic #Cobenfy #FDA #KarXT #Schizophrenia
Neelesh Prasad -
Cobenfy (KarXT): A More Atypical Antipsychotic for Treatment of Schizophrenia
Cobenfy (also known as KarXT), a combination of the drugs xanomeline and trospium chloride, has been studied to be effective for the treatment of...........
#Antipsychotic #Cobenfy #FDA #KarXT #Schizophrenia
Neelesh Prasad -
One of the most satisfying aspects of covering biotech as long as I have
is the opportunity to report on the long arc of drug development, from start to finish.
It’s not always pretty, and more often than not, it ends badly.But #KarXT, now #Cobenfy, is one of those drug stories with a happy ending.
I remember talking to #Steven #Paul in 2019 for a story about the phase 2 results,
which were pretty remarkable.
Paul was excited about what KarXT might mean for people with #schizophrenia,
but he was cautious because, as he warned me at the time,
clinical trials for psychiatric conditions are extraordinarily difficult to replicate.
Let’s wait to see what KarXT does in Ph3 trials, he said.
Now, we know.It’s been cool to follow and report on the KarXT story all these years.
From PureTech to Karuna to Bristol Myers Squibb,
and now, to #approval, where Cobenfy will have a meaningful impact on people living with schizophrenia ...-- Adam Feuerstein
https://x.com/adamfeuerstein/status/1839623238525055101